CRISPR Therapeutics AG (CRSP)
43.85
-0.50 (-1.13%)
USD |
NASDAQ |
Mar 28, 16:00
44.15
+0.30 (+0.68%)
After-Hours: 20:00
CRISPR Therapeutics Total Assets (Quarterly): 2.243B for Dec. 31, 2022
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 2.243B |
| September 30, 2022 | 2.353B |
| June 30, 2022 | 2.463B |
| March 31, 2022 | 2.606B |
| December 31, 2021 | 2.752B |
| September 30, 2021 | 2.822B |
| June 30, 2021 | 2.900B |
| March 31, 2021 | 1.958B |
| December 31, 2020 | 1.828B |
| September 30, 2020 | 1.485B |
| June 30, 2020 | 1.047B |
| March 31, 2020 | 1.007B |
| December 31, 2019 | 1.067B |
| September 30, 2019 | 720.59M |
| Date | Value |
|---|---|
| June 30, 2019 | 494.24M |
| March 31, 2019 | 497.87M |
| December 31, 2018 | 489.02M |
| September 30, 2018 | 518.90M |
| June 30, 2018 | 353.13M |
| March 31, 2018 | 374.45M |
| December 31, 2017 | 271.35M |
| September 30, 2017 | 282.32M |
| June 30, 2017 | 304.98M |
| March 31, 2017 | 322.35M |
| December 31, 2016 | 344.96M |
| September 30, 2016 | 278.65M |
| June 30, 2016 | 293.06M |
| December 31, 2015 | 159.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
353.13M
Minimum
Jun 2018
2.900B
Maximum
Jun 2021
1.499B
Average
1.276B
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 18.15B |
| Intellia Therapeutics Inc | 1.520B |
| Beam Therapeutics Inc | 1.342B |
| Moderna Inc | 25.86B |
| Editas Medicine Inc | 514.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 367.58M |
| Shareholders Equity (Quarterly) | 1.875B |
| Current Ratio | 15.30 |